Polarean Imaging Share Discussion Threads

[w t tutte] 23/2/2024 03:27

Posted yesterday.

[moontheloon] 20/2/2024 18:44

And who bought it

[wetdream] 20/2/2024 16:55

So who sold the 1.9m shares the other day?
Would have thought it was worth at TR1. 🤷

[epicsurf] 15/2/2024 16:48

Graft-versus-host disease, or #GVHD, is a medical condition that can occur after a bone marrow or stem cell transplant. In this condition, the donor cells (graft) attack the organs and tissues of the person receiving the transplant (host). There are two types of GVHD: acute (aGVHD) and chronic (cGVHD), and patients can develop either one or both types after the transplant.

Chronic GVHD can affect multiple organs, including the #lungs, and early detection of lung abnormalities is crucial for preserving pulmonary capacity. Patients with pulmonary GVHD often do not show any symptoms until the disease has progressed, so new ways to detect early changes in pulmonary function are desperately needed.

In honor of the 2nd ever #GVHDday taking place on February 17th, 2024, and to raise awareness about pulmonary GVHD, we invite you to explore the ongoing clinical trials linked in this post. In these studies, researchers are evaluating the role that Xenon MRI can play in monitoring patients post-stem cell transplant for GVHD manifestations in the lungs.

We extend gratitude to the organizations that comprise the #GVHDAlliance for their efforts in providing resources to and elevating the voices of the GVHD community. #GVHDconnect4hope
Source LinkedIn

[sandy12345] 15/2/2024 13:34

Could that be a delayed buy from yesterday?

[nigelpm] 15/2/2024 12:26

Well equally no one else wants in - price is driven by the seller - Amati given 6p is almost 15% below current market price

[moontheloon] 15/2/2024 12:21

Nukem adding from 10% would be a good sign. We know amati want out . No one else does

[nigelpm] 15/2/2024 11:53

Amati dumping more at 6p - presumably to Nukem again?

[goldbutler] 14/2/2024 17:05

polx 7.0p

The share price graph tells all here.

The stock market value of this company was between 50 - 100 million for many years.

Criticism of 'the market' on this board , was that it didn't know how to value such companies - utter rubbish of course .

The share price graph tells all - it is a reflection of all the players in the market view of the Board of Directors utter failure to use £27million to deliver any commercial traction to date. Investors stung for money by USA based Directors

Brokers figures of sales and equipment in use of 6 then 24 then 48 for the years 21 to 23E have not been delivered by Polarean directors.

In the meantime they and all their employees are paid very well

Asset managers are left wondering not about the technology but about those running the company.

So commercial traction where is it from the Chairman and the CCO Mr Dusek and Mr Brague with his cool $100000 for refining a strategy - which really should have been developed when they had 27million to play with.


Time to deliver Polarean Directors and that means for all shareholders.

Commercial traction and partnerships deals required.

[moontheloon] 14/2/2024 15:00

Keep trying they took my buy button off me

[nigelpm] 14/2/2024 14:21

I'll turn positive on commerical news - I still like the tech.

[nigelpm] 14/2/2024 14:21

:-) I actually quite liked that.

[moontheloon] 14/2/2024 14:15

I am whoever more surprised they let someone so negative have a buy button

[moontheloon] 14/2/2024 14:12

Not the normal scenario but they'll give a price to buy all my shares

[moontheloon] 14/2/2024 14:11

How much I was trying 7000 pounds all way down to 1000 all went negotiated

[nigelpm] 14/2/2024 13:58

Just did a test buy at 7p - no problem whatsoever.

[moontheloon] 14/2/2024 13:42

Can sell loads but can't buy any immediately all going to negotiated. They're well short of shares

[moontheloon] 14/2/2024 11:16

Looks due another tick

[sandy12345] 13/2/2024 13:42

Looks good for a revisit to 8p?

[moontheloon] 12/2/2024 11:12

As we know that system is nailed on and very close to rns

[w t tutte] 12/2/2024 10:23

This has just populated in the last few day ..... One would think Duke will need the FDA approved system for this ..... collaboration with the American Heart Association and validation work for POLX, that POLX does not have to pay for and its in a new indication.

[nigelpm] 11/2/2024 14:14

It's all in previous presentations.. that's not overly helpful though. Really it's a matter of where the next sales are coming from

[gclark] 11/2/2024 12:14

It would be really useful to know how much the kit sells for.
The consumables are presumably just the bottles, to provide on-going revenue, plus service contracts?
Any info available?

[nigelpm] 08/2/2024 16:25

There's a difference between something being needed and commercial.

That seems to be the problem here.